Anti-Obesity Effects of Aster spathulifolius Extract in High-Fat Diet-Induced Obese Rats

다국어 초록 (Multilingual Abstract)

The aim of this study was to investigate the anti-obesity and antihyperlipidemic efficacy and molecular mechanisms of Aster spathulifolius Maxim extract (ASE) in rats with high-fat diet (HFD)-induced obesity. Rats were separately fed a normal diet or a HFD for 8 weeks, then they were treated with ASE (62.5, 125, or 250 mg/kg) for another 4.5 weeks. The ASE supplementation significantly lowered body weight gain, visceral fat pad weights, serum lipid levels, as well as hepatic lipid levels in HFD-induced obese rats. Histological analysis showed that the ASE-treated group showed lowered numbers of lipid droplets and smaller size of adipocytes compared to the HFD group. To understand the mechanism of action of ASE, the expression of genes and proteins involved in obesity were measured in liver and skeletal muscle. The expression of fatty acid oxidation and thermogenesis-related genes (e.g., PPAR-α, ACO, CPT1, UCP2, and UCP3) of HFD-induced obese rats were increased by ASE treatment. On the other hand, ASE treatment resulted in decreased expression of fat intake-related gene ACC2 and lipogenesis-related genes (e.g., SREBP-1c, ACC1, FAS, SCD1, GPATR, AGPAT, and DGAT). Furthermore, ASE treatment increased the level of phosphorylated AMPKα in obese rats. Similarly, the level of phosphorylated ACC, a target protein of AMPKα in ASE groups, was increased by ASE treatment compared with the HFD group. These results suggest that ASE attenuated visceral fat accumulation and improved hyperlipidemia in HFD-induced obese rats by increasing lipid metabolism through the regulation of AMPK activity and the expression of genes and proteins involved in lipolysis and lipogenesis.

참고문헌 (Reference)

1 Rosen ED, "Transcriptional regulation of adipogenesis" 14 : 1293-1307, 2000

2 Thielecke F, "The potential role of green tea catechins in the prevention of the metabolic syndrome-A review" 70 : 11-24, 2009

3 Swain T, "The phenolic constituents of Prunus domestica. I.—The quantitative analysis of phenolic constituents" 10 : 63-68, 1959

4 Schoonjans K, "The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation" 1302 : 93-109, 1996

5 Hofbauer KG, "The obesity epidemic:Current and future pharmacological treatments" 47 : 565-592, 2007

6 Pi-Sunyer FX, "The obesity epidemic: Pathophysiology and consequences of obesity" 10 : 97S-104S, 2002

7 Kliewer SA, "The nuclear receptor PPARc-bigger than fat" 8 : 576-581, 1998

8 McGarry JD, "The mitochondrial carnitine palmitoyltransferase system—From concept to molecular analysis" 244 : 1-14, 1997

9 Eckel RH, "The metabolic syndrome" 365 : 1415-1428, 2005

10 Moller D, "Role of PPARs in the regulation of obesityrelated insulin sensitivity and inflammation" 27 : S17-S21, 2003

11 Turkish A, "Regulation of triglyceride metabolism. I. Eukaryotic neutral lipid synthesis: ‘‘Many ways to skin ACAT or a DGAT.’’" 292 : G953-G957, 2007

12 Auwerx J, "Regulation of triglyceride metabolism by PPARs: Fibrates and thiazolidinediones have distinct effects" 3 : 81-89, 1995

13 Fasshauer M, "Regulation of adipocytokines and insulin resistance" 46 : 1594-1603, 2003

14 Mayer MA, "Recent advances in obesity pharmacotherapy" 4 : 53-61, 2009

15 Yun JW, "Possible anti-obesity therapeutics from nature-A review" 71 : 1625-1641, 2010

16 Rayalam S, "Phytochemicals and regulation of the adipocyte life cycle" 19 : 717-726, 2008

17 Mandard S, "Peroxisome proliferator-activated receptor a target genes" 61 : 393-416, 2004

18 Arita Y, "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity" 257 : 79-83, 1999

19 Villarroya F, "PPARs in the control of uncoupling proteins gene expression" 2007 : 74364-, 2006

20 Boizard M, "Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors" 273 : 29164-29171, 1998

21 Moro C, "Obesity and medicinal plants" 71 : S73-S82, 2000

22 Bardou M, "Obesity and colorectal cancer" 62 : 933-947, 2013

23 Sartipy P, "Monocyte chemoattractant protein 1 in obesity and insulin resistance" 100 : 7265-7270, 2003

24 Browning JD, "Molecular mediators of hepatic steatosis and liver injury" 114 : 147-152, 2004

25 Ruderman NB, "Malonyl-CoA, fuel sensing, and insulin resistance" 276 : E1-E18, 1999

26 Lafontan M, "Lipolysis and lipid mobilization in human adipose tissue" 48 : 275-297, 2009

27 Lee E, "Lilium lancifolium Thunb. extract attenuates pulmonary inflammation and air space enlargement in a cigarette smoke-exposed mouse model" 149 : 148-156, 2013

28 Minokoshi Y, "Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase" 415 : 339-343, 2002

29 Maffei M, "Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects" 1 : 1155-1161, 1995

30 Lin L-Z, "Identification of the phenolic components of chrysanthemum flower (Chrysanthemum morifolium Ramat)" 120 : 319-326, 2010

31 Lin L-Z, "Identification of hydroxycinnamoylquinic acids of arnica flowers and burdock roots using a standardized LC-DAD-ESI/MS profiling method" 56 : 10105-10114, 2008

32 Jo J, "Hypertrophy and/or hyperplasia:Dynamics of adipose tissue growth" 5 : e1000324-, 2009

33 Lee H, "Galla Chinensis attenuates cigarette smoke-associated lung injury by inhibiting recruitment of inflammatory cells into the lung" 116 : 222-228, 2015

34 Coleman RA, "Enzymes of triacylglycerol synthesis and their regulation" 43 : 134-176, 2004

35 Bang CY, "Enzogenol improves diabetes-related metabolic change in C57BL/KsJ-db/db mice, a model of type 2diabetes mellitus" 66 : 875-885, 2014

36 Park M-Y, "Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-a, PPAR-c, and LPL mRNA expressions" 77 : 3344-3354, 2005

37 Bray GA, "Drug treatment of obesity" 2 : 403-418, 2001

38 이성옥, "Cytotoxic Terpene Hydroperoxides from the Aerial Parts of Aster spathulifolius" 대한약학회 29 (29): 845-848, 2006

39 Park H, "Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise" 277 : 32571-32577, 2002

40 Agarwal AK, "Congenital generalized lipodystrophy:Significance of triglyceride biosynthetic pathways" 14 : 214-221, 2003

41 Gauthier M-S, "Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis" 94 : 2127-2134, 2003

42 Lee JH, "Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells" 38 : 794-804, 2008

43 원지나, "Antiviral Activity of the Plant Extracts from Thuja orientalis, Aster spathulifolius, and Pinus thunbergii Against Influenza Virus A/PR/8/34" 한국미생물·생명공학회 23 (23): 125-130, 2013

44 Jang WS, "Antiobesity effects of the ethanol extract of Laminaria japonica Areshoung in high-fat-diet-induced obese rat" 2013 : 492807-, 2013

45 Yamauchi T, "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase" 8 : 1288-1295, 2002

46 Staiger H, "Adipocytokines: Fat-derived humoral mediators of metabolic homeostasis" 113 : 67-79, 2005

47 Rosen ED, "Adipocytes as regulators of energy balance and glucose homeostasis" 444 : 847-853, 2006

48 Hardie D, "AMPK: A key regulator of energy balance in the single cell and the whole organism" 32 : S7-S12, 2008

49 Kahn BB, "AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism" 1 : 15-25, 2005

50 Winder W, "AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes" 277 : E1-E10, 1999

51 Kim JB, "ADD1/SREBP1 activates PPARc through the production of endogenous ligand" 95 : 4333-4337, 1998

52 Folch J, "A simple method for the isolation and purification of total lipids from animal tissues" 226 : 497-509, 1957